Martin Michels,Markus Follmann,Alexandros Vakalopoulos,Katja Zimmermann,Nicole Teusch,Karen Engel
申请号：
US12996465
公开号：
US08551989B2
申请日:
2009.05.29
申请国别(地区):
US
年份:
2013
代理人:
摘要：
This invention relates to novel 4-(indazolyl)-1,4-dihydropyridine of the following formula (I) derivatives having protein tyrosine kinase inhibitory activity, to a process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions, particularly cancer and other proliferative disorders.
